|
|
||||||||
J Thorac Cardiovasc Surg 2003;125:863-871
© 2003 The American Association for Thoracic Surgery
Cardiopulmonary Support and Physiology |
From the Departments of Surgery,a Pathology,b and Biostatistics,c University of Alabama at Birmingham, Birmingham, Ala.
Received for publication Feb 14, 2002. Revisions requested April 30, 2002; revisions received May 24, 2002. Accepted for publication July 15, 2002. Address for reprints: William L. Holman, MD, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35294-0007 (E-mail: wholman{at}its.uab.edu).
Background: Preconditioning and inhibition of sodium-proton exchange attenuate myocardial ischemia-reperfusion injury by means of independent mechanisms that might act additively when used together. The hypothesis of this study is that treatment with a sodium-proton exchange inhibitor and a mitochondrial adenosine triphosphate-sensitive potassium channel opener produces superior functional recovery and a greater decrease in left ventricular infarct size compared with treatment with either drug alone in a model of severe global ischemia.
Methods: Isolated crystalloid-perfused rat hearts (n = 8 hearts per group) were administered vehicle (control, 0.04% dimethyl sulfoxide), diazoxide (100 µmol/L in 0.04% dimethyl sulfoxide), cariporide (10 µmol /L in 0.04% dimethyl sulfoxide), or diazoxide and cariporide before 40 minutes of ischemia at 35.5°C to 36.5°C and 30 minutes of reperfusion.
Results: The combination group had superior postischemic systolic function compared with that seen in the cariporide, diazoxide, and control groups (recovery of developed pressure: 91% ± 7% vs 26% ± 5%, 35% ± 6%, and 16% ± 3%, respectively; P < .05). Postischemic diastolic function in the combination group was superior compared with that seen in the other groups (changepre-post diastolic pressure of 67 ± 4 mm Hg with control, 49 ± 11 mm Hg with diazoxide, 59 ± 10 mm Hg with cariporide, and 3 ± 3 mm Hg with diazoxide and cariporide combination; P < .05). The left ventricular infarct area was less in the combination group compared with that in the cariporide, diazoxide, and control groups (6% ± 2% vs 35% ± 7%, 25% ± 3%, and 37% ± 9%, respectively; P < .05).
Conclusions: Combining a selective mitochondrial adenosine triphosphate-sensitive potassium channel opener with a selective reversible inhibitor of sarcolemmal sodium-proton exchange improves recovery of contractile function from severe global ischemia in the isolated buffer-perfused rat heart. The putative mechanism for this benefit is superior protection of mitochondrial function.
This article has been cited by other articles:
![]() |
P. Wang, C. Zaragoza, and W. Holman Sodium-Hydrogen Exchange Inhibition and {beta}-Blockade Additively Decrease Infarct Size Ann. Thorac. Surg., March 1, 2007; 83(3): 1121 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Davies, S. B. Digerness, C. R. Killingsworth, C. Zaragoza, C. R. Katholi, R. K. Justice, S. P. Goldberg, and W. L. Holman Multiple Treatment Approach to Limit Cardiac Ischemia-Reperfusion Injury Ann. Thorac. Surg., October 1, 2005; 80(4): 1408 - 1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Brookes, Y. Yoon, J. L. Robotham, M. W. Anders, and S.-S. Sheu Calcium, ATP, and ROS: a mitochondrial love-hate triangle Am J Physiol Cell Physiol, October 1, 2004; 287(4): C817 - C833. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |